Skip to main content
Download PDF

A novel variant in the ROR2 gene underlying brachydactyly type B: a case report

BMC Pediatrics volume 22, Article number: 528 (2022) Cite this article

Abstract

Background

Brachydactyly type B is an autosomal dominant disorder that is characterized by hypoplasia of the distal phalanges and nails and can be divided into brachydactyly type B1 (BDB1) and brachydactyly type B2 (BDB2). BDB1 is the most severe form of brachydactyly and is caused by truncating variants in the receptor tyrosine kinase–like orphan receptor 2 (ROR2) gene.

Case presentation

Here, we report a five-generation Chinese family with brachydactyly with or without syndactyly. The proband and her mother underwent digital separation in syndactyly, and the genetic analyses of the proband and her parents were provided. The novel heterozygous frameshift variant c.1320dupG, p.(Arg441Alafs*18) in the ROR2 gene was identified in the affected individuals by whole-exome sequencing and Sanger sequencing. The c.1320dupG variant in ROR2 is predicted to produce a truncated protein that lacks tyrosine kinase and serine/threonine- and proline-rich structures and remarkably alters the tertiary structures of the mutant ROR2 protein.

Conclusion

The c.1320dupG, p.(Arg441Alafs*18) variant in the ROR2 gene has not been reported in any databases thus far and therefore is novel. Our study extends the gene variant spectrum of brachydactyly and may provide information for the genetic counselling of family members.

Peer Review reports

Background

Brachydactyly (BD) is an autosomal dominant hand and foot malformation that is characterized by abnormally shortened or missing phalanges and/or metacarpals/metatarsals [1]. It may occur as an isolated trait or as part of a complex malformation syndrome [2]. According to the Bell classification, heritable isolated BDs have been classified into subtypes A to E according to their patterns of skeletal involvement [3]. Clinical features and pathogenic genes of isolated BDs are listed in Table 1 [4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20]. Brachydactyly type B1 (BDB1, OMIM 113,000) is the most severe form of brachydactyly and is characterized by shortening or hypoplasia of the distal and middle phalanges of digits 2 through 5 with or without nail dysplasia, fusion of the middle and distal phalanges, variable degrees of distal and proximal symphalangism, and a broad or bifid thumb. The feet are similarly but less severely affected [13,14,15].

Table 1 Types of isolated brachydactyly
Full size table

BDB1 is usually caused by a heterozygous variant in the receptor tyrosine kinase (RTK)-like orphan receptor 2 (ROR2) gene (OMIM 602,337), which is located on chromosome 9q22.31 [14, 21]. The ROR2 gene contains nine exons and spans a genomic length of approximately 228 kb. The ROR2 protein contains 943 amino acids and belongs to the ROR family of RTKs. It consists of an extracellular region, a transmembrane section, and an intracellular region [22]. Heterozygous variants that truncate the intracellular portion of ROR2, either the N-terminal or C-terminal of the TK domain, are the leading causes of BDB1 [22, 23]. In addition, homozygous or compound heterozygous variants in the ROR2 gene are responsible for recessive Robinow syndrome [22].

In recent years, whole-exome sequencing has become a routine strategy for discovering potential causal variants in inherited Mendelian disorders. It provides a cost-effective, fast-track approach to variant discovery and considerably increases the overall diagnostic rate. In this study, we identified the disease-causing variant in a five-generation Chinese family with BDB1 using whole-exome sequencing and Sanger sequencing. Pathogenicity was inferred by bioinformatic analysis.

Case presentation

A five-generation Chinese family with BDB1 was recruited at Central Hospital Affiliated to Shenyang Medical College. Clinical information of all family members and blood specimens from the proband and her parents were obtained. Among the 13 affected individuals, 10 had brachydactyly, and the remaining three had brachydactyly with syndactyly (Fig. 1). The 1-year-old female proband was physically examined and received a radiographic examination of the right hand before surgery. She exhibited bilateral shortening and hypoplasia of the distal and middle phalanges of digits 2 to 5 with cutaneous syndactyly of right fingers 3 to 4. The proband underwent digital separation on her right hand. Her mother underwent digital separation on both hands before enrolment in this study. Therefore, her phenotypic information was determined after reviewing her medical records and performing a physical examination. She had shortening/hypoplasia of the distal and middle phalanges of digits 2 to 5 with cutaneous syndactyly of fingers 3 to 4 on both hands, and she also had a broad hallux on both feet with nail dysplasia (Fig. 2). The phenotypic information of the other family members was provided by the proband’s mother.

Fig. 1
figure 1

Pedigree of the family with BDB1. Black shading on the left half represents brachydactyly, and grey shading on the right half represents syndactyly. The proband is marked by an arrow

Full size image
Fig. 2
figure 2

Phenotype of the proband and her mother. a A photograph of the proband's right hand before surgery. b An X-ray of the proband’s right hand before surgery. c A picture of the proband’s hands after the operation. d A photograph of the proband's feet. e A photograph of the mother’s hands after the operation. f A photograph of the mother’s feet

Full size image

Genomic DNA was extracted from the peripheral venous blood of the proband using the QIAamp DNA Blood Mini Kit (QIAGEN, Hilden, Germany) according to the manufacturer’s protocol and the AI Exome V1 Kit (iGeneTech, AIEV1). The extracted DNA was used for whole-exome capture and enrichment. Exome sequencing was performed on the NovaSeq 6000 sequencing platform (Illumina). Gene variants were initially annotated using the wANNOVAR tool (http://wannovar.wglab.org/). Those variants with minor allele frequencies greater than 0.01 according to public genomic databases, such as 1000Genomes, dbSNP, Exome Variant Server, gnomAD, and the Exome Aggregation Consortium were filtered out. The c.1320dupG, p.(Arg441Alafs*18) variant was identified in exon 8 of ROR2 by whole-exome sequencing and Sanger sequencing. This variant results in a frameshift at amino acid position 441. This frameshift creates a polypeptide chain of 17 new amino acids and a premature termination codon at amino acid position 458. To read the duplication sequencing chromatogram more clearly, the purified PCR fragment of the proband was inserted into the pMD-18 T vector. The selected clones were sequenced using the universal primers M13F and M13R (Fig. 3a). At the protein level, the c.1320dupG variant is predicted to produce a truncated protein that lacks tyrosine kinase and serine/threonine- and proline-rich structures, resulting in a loss of the whole intracellular region (Fig. 3b). Three-dimensional structures of wild-type and mutant ROR2 proteins were generated by the Robetta online server (http://robetta.org/) and validated using different parameters, such as the Ramachandran plot, ERRAT score, confidence and P value [24, 25]. The first two parameters were calculated using Structure Analysis and Verification Server (SAVES) version 6.0 (https://saves.mbi.ucla.edu/), and the last two parameters were determined using the ModFOLD Model Quality Assessment Server (https://www.reading.ac.uk/bioinf/ModFOLD/) [26,27,28,29]. Illustrations were prepared using VMD (www.ks.uiuc.edu/Research/vmd/). Molecular modelling shows that p.(Arg441Alafs*18) severely affects the tertiary structure of the remaining peptide chain of ROR2 (Fig. 4). The Ramachandran plot shows that the total number of residues in the most favoured regions for the wild-type and mutant ROR2 proteins was 688 (85.9%) and 330 (86.2%), respectively, and the corresponding number of residues in disallowed regions was 5 (0.6%) and 4 (1.0%), respectively. The ERRAT scores of wild-type and mutant ROR2 proteins were 89.732 and 86.9863, respectively. The confidence scores and P values of the wild-type (0.04122) and mutant proteins (0.05723) were less than 0.1 (Additional file 1). The above results indicate that the three-dimensional structures of the wild-type and mutant ROR2 proteins we predicted were reliable.

Fig. 3
figure 3

Gene variant analysis of a family with BDB1. a The novel heterozygous variant c.1320dupG, p.(Arg441Alafs*18) in ROR2 was verified by Sanger sequencing. The variant is marked by a red arrow. CS: Clone sequencing. b A schematic diagram showing the encoded domain structure of the ROR2 gene. A recurrent variant is marked in black, and the novel variant identified in this study is highlighted in red. This ROR2 variant results in the loss of the whole intracellular region

Full size image
Fig. 4
figure 4

Three-dimensional structures of the wild-type and variant ROR2 proteins. Molecular modelling by Robetta showing that p.(Arg441Alafs*18) remarkably altered the tertiary structures of the remaining peptide chain of the ROR2 protein. a Wild-type; b Mutant type

Full size image

Discussion and conclusion

ROR2 is a single-pass transmembrane protein. The domain structure of ROR2 is composed of an extracellular immunoglobulin-like domain (Ig, aa residues 55–145), frizzled-like cysteine-rich domain (FRZ or CRD, aa residues 169–303), Kringle domain (Kr, aa residues 316–394), transmembrane domain (TM, aa residues 404–424), and intracellular tyrosine kinase (TK, aa residues 473–746), and serine/threonine-rich (ST1, aa residues 753–782; ST2, aa residues 859–882) and proline-rich (PRD, aa residues 784–857) structures [22]. The extracellular region interacts with Wnt5a, which binds to the CRD region of ROR2 [30]. Both canonical and noncanonical Wnt5a/Ror2 signalling play an important role in limb skeletal development and morphogenesis [30,31,32]. The intracellular region of ROR2 is associated with many factors, such as 14–3-3 protein beta/alpha, nuclear receptor subfamily 2 group C member 2, proto-oncogene tyrosine-protein kinase Src, Wilms tumour protein 1-interacting protein, and SHC-transforming protein 1 [23, 30, 33,34,35,36]. Activation of ROR2 kinase requires the intracellular C-terminal region for recruitment of the nonreceptor kinase Src [34, 37].

Up to the time of this article’s publication, a total of 15 different variants in the ROR2 gene were found to be associated with BDB1 (Table 2). All the documented BDB1-causing ROR2 variants were nonsense or frameshift variants and were clustered in the last two exons (exons 8 and 9) or in the last intron (intron 8). Thus, the mutant mRNAs were able to escape degradation by nonsense-mediated decay, resulting in a partial or complete truncation of the intracellular portion of the ROR2 protein [38]. These mutations are believed to have a specific gain-of-function effect, not a simple haploinsufficiency [39]. The BDB1-related variants can be divided into distal and proximal variants. The distal variant that is located after TK produces a truncated protein that lacks the ST1, ST2, and PRD domains, leading to a more severe phenotype [14, 40]. In contrast, the proximal variant results in a loss of the whole intracellular region, causing a less severe but more variable phenotype [37].

Table 2 Clinical manifestation of ROR2 causing BDB1
Full size table

In this study, the novel proximal frameshift variant c.1320dupG, p.(Arg441Alafs*18) in the ROR2 gene was identified in a Chinese family with BDB1. This variant is predicted to produce a premature termination codon at amino acid position 458 and a new polypeptide consisting of 17 amino acids at the variant position. The location of this variant was very similar to the locations of c.1321_1325delCGGCG, p.(Arg441Thrfs*16), and c.1324C > T, p.(Arg442*), but their phenotypes were different. Individuals heterozygous for c.1321_1325delCGGCG, p.(Arg441Thrfs*16) exhibited bilateral hypoplasia of the distal and middle phalanges of the fingers and toes 2 to 5 to varying degrees, with or without hypoplasia of the nails. In contrast, individuals homozygous for c.1321_1325delCGGCG, p.(Arg441Thrfs*16), showed severe skeletal defects that primarily affected the distal limbs and the spine [14]. Interestingly, a heterozygous c.1324C > T, p.(R442*) carrier had a normal limb phenotype, and a homozygous c.1324C > T, p.(R442*) individual exhibited features of recessive Robinow syndrome in conjunction with severe recessive brachydactyly [39]. The c.1320dupG, p.(Arg441Alafs*18) variant in the ROR2 gene reported by our study caused bilateral or unilateral shortening/hypoplasia of the distal and middle phalanges of digits 2 to 5 with or without cutaneous syndactyly of fingers 3 to 4. The relationship between the ROR2 gene variants and phenotypes is not completely clear. Previous studies suggest that BDB1 variants result in a gain in function, whereas Robinow syndrome variants result in a loss of function [14, 49]. Further research should investigate the reasons for the different phenotypes resulting from these similar gene variants.

In conclusion, we report the novel variant c.1320dupG, p.(Arg441Alafs*18) in the ROR2 gene in a Chinese family with BDB1. Our study extends the gene variant spectrum of BDB1 and provides information for the genetic counselling of family members.

Availability of data and materials

The datasets generated and/or analysed during the current study are available in the NCBI Sequence Read Archive (SRA) repository (accession number: SRP390837).

Abbreviations

BD:

Brachydactyly

BDB1:

Brachydactyly type B1

RTK:

Receptor tyrosine kinase

Ig:

Immunoglobulin-like domain

FRZ or CRD:

Frizzled-like cysteine-rich domain

Kr:

Kringle domain

TM:

Transmembrane domain

TK:

Intracellular tyrosine kinase

ST1 ST2:

Serine/threonine-rich

PRD:

Proline-rich

References

  1. Temtamy SA, Aglan MS. Brachydactyly. Orphanet J Rare Dis. 2008;3:15. https://doi.org/10.1186/1750-1172-3-15.

    Article  PubMed  PubMed Central  Google Scholar 

  2. David A, Vincent M, Quéré MP, Lefrançois T, Frampas E, David A. Isolated and syndromic brachydactylies: diagnostic value of hand X-rays. Diagn Interv Imaging. 2015;96(5):443–8. https://doi.org/10.1016/j.diii.2014.12.007.

    Article  CAS  PubMed  Google Scholar 

  3. Bell J. On brachydactyly and symphalangism. In: Penrose LS, editor. Treasury of Human Inheritance. London: Cambridge University Press; 1951. p. 191–201.

    Google Scholar 

  4. Gao B, Guo J, She C, Shu A, Yang M, Tan Z, et al. Mutations in IHH, encoding Indian hedgehog, cause brachydactyly type A-1. Nat Genet. 2001;28(4):386–8. https://doi.org/10.1038/ng577.

    Article  CAS  PubMed  Google Scholar 

  5. Armour CM, McCready ME, Baig A, Hunter AG, Bulman DE. A novel locus for brachydactyly type A1 on chromosome 5p13.3-p13.3.2. J Med Genet. 2002;39(3):186–8. https://doi.org/10.1136/jmg.39.3.186.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Byrnes AM, Racacho L, Nikkel SM, Xiao F, MacDonald H, Underhill TM, et al. Mutations in GDF5 presenting as semidominant brachydactyly A1. Hum Mutat. 2010;31(10):1155–62. https://doi.org/10.1002/humu.21338.

    Article  CAS  PubMed  Google Scholar 

  7. Racacho L, Byrnes AM, MacDonald H, Dranse HJ, Nikkel SM, Allanson J, et al. Two novel disease-causing variants in BMPR1B are associated with brachydactyly type A1. Eur J Hum Genet. 2015;23(12):1640–5. https://doi.org/10.1038/ejhg.2015.38.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Lehmann K, Seemann P, Boergermann J, Morin G, Reif S, Knaus P, et al. A novel R486Q mutation in BMPR1B resulting in either a brachydactyly type C/symphalangism-like phenotype or brachydactyly type A2. Eur J Hum Genet. 2006;14(12):1248–54. https://doi.org/10.1038/sj.ejhg.5201708.

    Article  CAS  PubMed  Google Scholar 

  9. Seemann P, Schwappacher R, Kjaer KW, Krakow D, Lehmann K, Dawson K, et al. Activating and deactivating mutations in the receptor interaction site of GDF5 cause symphalangism or brachydactyly type A2. J Clin Invest. 2005;115(9):2373–81. https://doi.org/10.1172/JCI25118.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Dathe K, Kjaer KW, Brehm A, Meinecke P, Nürnberg P, Neto JC, et al. Duplications involving a conserved regulatory element downstream of BMP2 are associated with brachydactyly type A2. Am J Hum Genet. 2009;84(4):483–92. https://doi.org/10.1016/j.ajhg.2009.03.001.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Zhang M, Lu L, Wei B, Zhang Y, Li X, Shi Y, et al. Brachydactyly type A3 is caused by a novel 13 bp HOXD13 frameshift deletion in a Chinese family. Am J Med Genet A. 2020;182(10):2432–6. https://doi.org/10.1002/ajmg.a.61788.

    Article  CAS  PubMed  Google Scholar 

  12. Zhao X, Sun M, Zhao J, Leyva JA, Zhu H, Yang W, et al. Mutations in HOXD13 underlie syndactyly type V and a novel brachydactyly-syndactyly syndrome. Am J Hum Genet. 2007;80(2):361–71. https://doi.org/10.1086/511387.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Oldridge M, Temple IK, Santos HG, Gibbons RJ, Mustafa Z, Chapman KE, et al. Brachydactyly type B: linkage to chromosome 9q22 and evidence for genetic heterogeneity. Am J Hum Genet. 1999;64(2):578–85. https://doi.org/10.1086/302255.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Schwabe GC, Tinschert S, Buschow C, Meinecke P, Wolff G, Gillessen-Kaesbach G, et al. Distinct mutations in the receptor tyrosine kinase gene ROR2 cause brachydactyly type B. Am J Hum Genet. 2000;67(4):822–31. https://doi.org/10.1086/303084.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Mundlos S. The brachydactylies: a molecular disease family. Clin Genet. 2009;76(2):123–36. https://doi.org/10.1111/j.1399-0004.2009.01238.x.

    Article  CAS  PubMed  Google Scholar 

  16. Lehmann K, Seemann P, Silan F, Goecke TO, Irgang S, Kjaer KW, et al. A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN. Am J Hum Genet. 2007;81(2):388–96. https://doi.org/10.1086/519697.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Faryal S, Farooq M, Abdullah U, Ali Z, Saadi SM, Ullah F, et al. A GDF5 frameshift mutation segregating with Grebe type chondrodysplasia and brachydactyly type C+ in a 6 generations family: Clinical report and mini review. Eur J Med Genet. 2021;64(7): 104226. https://doi.org/10.1016/j.ejmg.2021.104226.

    Article  CAS  PubMed  Google Scholar 

  18. Johnson D, Kan SH, Oldridge M, Trembath RC, Roche P, Esnouf RM, et al. Missense mutations in the homeodomain of HOXD13 are associated with brachydactyly types D and E. Am J Hum Genet. 2003;72(4):984–97. https://doi.org/10.1086/374721.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Thomas-Teinturier C, Pereda A, Garin I, Diez-Lopez I, Linglart A, Silve C, et al. Report of two novel mutations in PTHLH associated with brachydactyly type E and literature review. Am J Med Genet A. 2016;170(3):734–42. https://doi.org/10.1002/ajmg.a.37490.

    Article  CAS  PubMed  Google Scholar 

  20. Pereda A, Garin I, Garcia-Barcina M, Gener B, Beristain E, Ibañez AM, et al. Brachydactyly E: isolated or as a feature of a syndrome. Orphanet J Rare Dis. 2013;8:141. https://doi.org/10.1186/1750-1172-8-141.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Gong Y, Chitayat D, Kerr B, Chen T, Babul-Hirji R, Pal A, et al. Brachydactyly type B: clinical description, genetic mapping to chromosome 9q, and evidence for a shared ancestral mutation. Am J Hum Genet. 1999;64(2):570–7. https://doi.org/10.1086/302249.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Afzal AR, Jeffery S. One gene, two phenotypes: ROR2 mutations in autosomal recessive robinow syndrome and autosomal dominant brachydactyly type B. Hum Mutat. 2003;22(1):1–11. https://doi.org/10.1002/humu.10233.

    Article  CAS  PubMed  Google Scholar 

  23. Stricker S, Rauschenberger V, Schambony A. ROR-family receptor tyrosine kinases. Curr Top Dev Biol. 2017;123:105–42. https://doi.org/10.1016/bs.ctdb.2016.09.003.

    Article  CAS  PubMed  Google Scholar 

  24. Kim DE, Chivian D, Baker D. Protein structure prediction and analysis using the Robetta server. Nucleic Acids Res. 2004;32:W526–31. https://doi.org/10.1093/nar/gkh468.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Baek M, DiMaio F, Anishchenko I, Dauparas J, Ovchinnikov S, Lee GR, et al. Accurate prediction of protein structures and interactions using a three-track neural network. Science. 2021;373(6557):871–6. https://doi.org/10.1126/science.abj8754.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Gurung AB. In silico structure modelling of SARS-CoV-2 Nsp13 helicase and Nsp14 and repurposing of FDA approved antiviral drugs as dual inhibitors. Gene Rep. 2020;21: 100860. https://doi.org/10.1016/j.genrep.2020.100860.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Maghrabi AHA, McGuffin LJ. ModFOLD6: an accurate web server for the global and local quality estimation of 3D protein models. Nucleic Acids Res. 2017;45(W1):W416–21. https://doi.org/10.1093/nar/gkx332.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. McGuffin LJ, Shuid AN, Kempster R, Maghrabi AHA, Nealon JO, Salehe BR, et al. Accurate template-based modeling in CASP12 using the IntFOLD4-TS, ModFOLD6, and ReFOLD methods. Proteins. 2018;86(Suppl 1):335–44. https://doi.org/10.1002/prot.25360.

    Article  CAS  PubMed  Google Scholar 

  29. McGuffin LJ, Aldowsari FMF, Alharbi SMA, Adiyaman R. ModFOLD8: accurate global and local quality estimates for 3D protein models. Nucleic Acids Res. 2021;49(W1):W425–30. https://doi.org/10.1093/nar/gkab321.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Minami Y, Oishi I, Endo M, Nishita M. Ror-family receptor tyrosine kinases in noncanonical Wnt signaling: their implications in developmental morphogenesis and human diseases. Dev Dyn. 2010;239(1):1–15. https://doi.org/10.1002/dvdy.21991.

    Article  CAS  PubMed  Google Scholar 

  31. Bernatik O, Radaszkiewicz T, Behal M, Dave Z, Witte F, Mahl A, et al. A novel role for the BMP antagonist noggin in sensitizing cells to non-canonical Wnt-5a/Ror2/disheveled pathway activation. Front Cell Dev Biol. 2017;5:47. https://doi.org/10.3389/fcell.2017.00047.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Kamizaki K, Endo M, Minami Y, Kobayashi Y. Role of noncanonical Wnt ligands and Ror-family receptor tyrosine kinases in the development, regeneration, and diseases of the musculoskeletal system. Dev Dyn. 2021;250(1):27–38. https://doi.org/10.1002/dvdy.151.

    Article  PubMed  Google Scholar 

  33. Liu Y, Ross JF, Bodine PV, Billiard J. Homodimerization of Ror2 tyrosine kinase receptor induces 14–3-3(beta) phosphorylation and promotes osteoblast differentiation and bone formation. Mol Endocrinol. 2007;21(12):3050–61. https://doi.org/10.1210/me.2007-0323.

    Article  CAS  PubMed  Google Scholar 

  34. Akbarzadeh S, Wheldon LM, Sweet SM, Talma S, Mardakheh FK, Heath JK. The deleted in brachydactyly B domain of ROR2 is required for receptor activation by recruitment of Src. PLoS ONE. 2008;3(3): e1873. https://doi.org/10.1371/journal.pone.0001873.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Feike AC, Rachor K, Gentzel M, Schambony A. Wnt5a/Ror2-induced upregulation of xPAPC requires xShcA. Biochem Biophys Res Commun. 2010;400(4):500–6. https://doi.org/10.1016/j.bbrc.2010.08.074.

    Article  CAS  PubMed  Google Scholar 

  36. Dickinson SC, Sutton CA, Brady K, Salerno A, Katopodi T, Williams RL, et al. The Wnt5a receptor, receptor tyrosine kinase-like orphan receptor 2, is a predictive cell surface marker of human mesenchymal stem cells with an enhanced capacity for Chondrogenic differentiation. Stem Cells. 2017;35(11):2280–91. https://doi.org/10.1002/stem.2691.

    Article  CAS  PubMed  Google Scholar 

  37. Dong S, Wang Y, Tao S, Zheng F. Mutation screening in candidate genes in four Chinese brachydactyly families. Ann Clin Lab Sci. 2015;45(1):94–9.

    CAS  PubMed  Google Scholar 

  38. Lv D, Luo Y, Yang W, Cao L, Wen Y, Zhao X, et al. A novel single-base deletion in ROR2 causes atypical brachydactyly type B1 with cutaneous syndactyly in a large Chinese family. J Hum Genet. 2009;54(7):422–5. https://doi.org/10.1038/jhg.2009.48.

    Article  CAS  PubMed  Google Scholar 

  39. Schwarzer W, Witte F, Rajab A, Mundlos S, Stricker S. A gradient of ROR2 protein stability and membrane localization confers brachydactyly type B or Robinow syndrome phenotypes. Hum Mol Genet. 2009;18(21):4013–21. https://doi.org/10.1093/hmg/ddp345.

    Article  CAS  PubMed  Google Scholar 

  40. Hamamy H, Saleh N, Oldridge M, Al-Hadidy A, Ajlouni K. Brachydactyly type B1: report of a family with de novo ROR2 mutation. Clin Genet. 2006;70(6):538–40. https://doi.org/10.1111/j.1399-0004.2006.00719.x.

    Article  CAS  PubMed  Google Scholar 

  41. Oldridge M, Fortuna AM, Maringa M, Propping P, Mansour S, Pollitt C, et al. Dominant mutations in ROR2, encoding an orphan receptor tyrosine kinase, cause brachydactyly type B. Nat Genet. 2000;24(3):275–8. https://doi.org/10.1038/73495.

    Article  CAS  PubMed  Google Scholar 

  42. Bacchelli C, Wilson LC, Cook JA, Winter RM, Goodman FR. ROR2 is mutated in hereditary brachydactyly with nail dysplasia, but not in Sorsby syndrome. Clin Genet. 2003;64(3):263–5. https://doi.org/10.1034/j.1399-0004.2003.00139.x.

    Article  CAS  PubMed  Google Scholar 

  43. Qin L, Lou G, Guo L, Zhang Y, Wang H, Wang L, et al. Targeted next-generation sequencing-based molecular diagnosis of congenital hand malformations in Chinese population. Sci Rep. 2018;8(1):12721. https://doi.org/10.1038/s41598-018-30940-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Li CM, Wang FY, Sun WW, Han SL, Chang MX, Feng HG. Mutation analysis of the pathogenic gene in a Chinese family with Brachydactyly type B1. Yi Chuan. 2011;33(2):147–52. https://doi.org/10.3724/sp.j.1005.2011.00147.

    Article  PubMed  Google Scholar 

  45. Jourdain AS, Petit F, Odou MF, Balduyck M, Brunelle P, Dufour W, et al. Multiplex targeted high-throughput sequencing in a series of 352 patients with congenital limb malformations. Hum Mutat. 2020;41(1):222–39. https://doi.org/10.1002/humu.23912.

    Article  CAS  PubMed  Google Scholar 

  46. Huang D, Jiang S, Zhang Y, Liu X, Zhang J, He R. A new mutation in the gene ROR2 causes brachydactyly type B1. Gene. 2014;547(1):106–10. https://doi.org/10.1016/j.gene.2014.06.035.

    Article  CAS  PubMed  Google Scholar 

  47. Tufan F, Cefle K, Türkmen S, Türkmen A, Zorba U, Dursun M, et al. Clinical and molecular characterization of two adults with autosomal recessive Robinow syndrome. Am J Med Genet A. 2005;136(2):185–9. https://doi.org/10.1002/ajmg.a.30785.

    Article  PubMed  Google Scholar 

  48. Kjaer KW, Tiner M, Cingoz S, Karatosun V, Tommerup N, Mundlos S, et al. A novel subtype of distal symphalangism affecting only the 4th finger. Am J Med Genet A. 2009;149A(7):1571–3. https://doi.org/10.1002/ajmg.a.32905.

    Article  PubMed  Google Scholar 

  49. Kirat E, Mutlu Albayrak H, Sahinoglu B, Gurler AI, Karaer K. Autosomal recessive Robinow syndrome with novel ROR2 variants: distinct cases exhibiting the clinical variability. Clin Dysmorphol. 2020;29(3):137–40. https://doi.org/10.1097/mcd.0000000000000319.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank all of the family members for their contributions to this work.

Funding

This work was supported by the Natural Science Foundation of China (81670896). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author information

Authors and Affiliations

  1. College of Kinesiology, Shenyang Sport University, No. 36 Jinqiansong East Road, Sujiatun District, Shenyang, 110102, China

    Jiaqi Shao, Shuyang Zhao, Weisheng Sun & Lihua Cao

  2. Hand SurgeryCentral Hospital Affiliated to Shenyang Medical CollegeTiexi District, Dept.4No. 5 Nanqi West Road, Shenyang, 110024, China

    Yue Liu & Jie Zhan

Authors
  1. Jiaqi Shao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yue Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shuyang Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Weisheng Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jie Zhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lihua Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

LHC designed the study and prepared the article. YL and JZ obtained the clinical information. JQS performed the experiments. SYZ and WSS analyzed experimental data. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Jie Zhan or Lihua Cao.

Ethics declarations

Ethics approval and consent to participate

This study adhered to the tenets of the Declaration of Helsinki and was approved by the Central Hospital Affiliated to Shenyang Medical College Institutional Review Board. Written informed consent was obtained from all participants.

Consent for publication

Written informed consent for publication was obtained from patient’s parents, also the individual information of the family members of this case report.

Competing interests

All authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

The results of three-dimensional structures of wild-type and mutant ROR2 proteins were validated using different parameters.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shao, J., Liu, Y., Zhao, S. et al. A novel variant in the ROR2 gene underlying brachydactyly type B: a case report. BMC Pediatr 22, 528 (2022). https://doi.org/10.1186/s12887-022-03564-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12887-022-03564-z

Keywords

  • Brachydactyly type B1
  • ROR2
  • Whole-exome sequencing
  • Variant

BMC Pediatrics

ISSN: 1471-2431

Contact us